STUDY OF PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL.

Reid AE. Non-alcoholic fatty liver disease. In: Feldman M, Frieddman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver disease. 9th edn. Philadelphia: 2010: p. 1401-11.

Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. Q J Med 2010;103(2):71-83.        

Caldwell SH, Argo CK. Non-alcoholic fatty liver disease and nutrition. In: Dooley JS, Lok ASF, Burroughs AK, et al. eds. Sherlock’s Diseases of the liver and biliary system. 12th edn. West Sussex 2011: p. 546-62.

Chawla YK, Taneja S. Non-Alcoholic fatty liver disease. In: Munjal YP, Sharma SK, eds. API Textbook of Medicine 9th edn. Mumbai: 2012: p. 885-7.

Bacon BR. Genetic, Metabolic and infiltrative diseases affecting the liver. In: Fauci, Braunwald, Kasper, eds. Harrison’s Principles of internal medicine. 18th edn. New York: McGraw-Hill Publications 2012: p. 2603-5.

Day CP, James OF. Steatohepatitis: a tale of two ‘hits’? Gastroenterology 1998;114(4):842-5.        

Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in non-alcoholic fatty liver disease. Semin Liver Dis 2008;28(4):370-9.             

Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am J Pathol 2003;163(4):1301-11.   

Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130(8):671-80.      

Younossi ZM. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2008;28(1):2-12.                   

Huang XD, Fan Y, Zhang H, et al. Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol 2008;14(18):2888-93.       

Uygun A, Kadayifci A, Yesilova Z, et al. Serum leptin levels patients with non-alcoholic steatohepatitis. Am J Gastroenterol 2000;95(12):3584-9.       

Targher G, Bertolini L, Padovani R, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007;30(5):1212-8.           

Agarwal AK, Jain V, Singla S, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India 2011;59:351-4. 

Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology 2005;42(1):44-52.